-
ENDRA Life Sciences Appoints Irina Pestrikova as Senior Director of Finance, Announces Departure of CFO David Wells
Jun 15, 2021
ANN ARBOR, MI / ACCESSWIRE / June 15, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced the appointment of Irina Pestrikova as Senior...read more > -
ENDRA Life Sciences Set to Join the Russell Microcap(R) Index
Jun 9, 2021
ANN ARBOR, MI / ACCESSWIRE / June 9, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that it is expected to be added to the Russell...read more > -
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
May 17, 2021
Conference call begins at 4:30 p.m. Eastern time today...read more > -
ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021
May 6, 2021
ANN ARBOR, MI / ACCESSWIRE / May 6, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results...read more > -
ENDRA Life Sciences Further Strengthens TAEUS(R) System's Intellectual Property Protection with Issuance of Two U.S. Patents
May 4, 2021
ANN ARBOR, MI / ACCESSWIRE / May 4, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the Company has recently been issued U.S. Paten...read more > -
ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting
Apr 8, 2021
ANN ARBOR, MI / ACCESSWIRE / April 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the Company's Chief Techno...read more > -
ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update
Mar 25, 2021
Conference call begins at 4:30 p.m. Eastern time today...read more > -
ENDRA Life Sciences and Hepion Pharmaceuticals Partner to Drive Efficiencies in NASH Clinical Trials
Mar 18, 2021
Hepion to include ENDRA's TAEUSⓇ technology in Phase 2b trial of CRV431...read more > -
ENDRA Life Sciences to Report Fourth Quarter 2020 Financial Results on March 25, 2021
Mar 17, 2021
ANN ARBOR, MI / ACCESSWIRE / March 17, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial resu...read more > -
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
Mar 2, 2021
ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in t...read more >
